Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02337231 · ClinicalTrials.gov registry record · NA
Botanical Oils Study to Determine Genetic Differences in the Way Your Body Processes Fats in Edible Oils
A NA study of Genetic Differences of Lipid Metabolism/Healthy Subjects, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT02337231: Completed NA study of Genetic Differences of Lipid Metabolism/Healthy Subjects, sponsored by Wake Forest University Health Sciences.
NCT02337231 is a NA study of Genetic Differences of Lipid Metabolism/Healthy Subjects that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02337231, a NA study of Genetic Differences of Lipid Metabolism/Healthy Subjects, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, controlled, cross-over clinical trial of borage oil vs soybean oil to determine whether the metabolism and/or impact of medium chain-polyunsaturated fatty acids (MC-PUFAs) in botanical oil supplements are changed in relationship to specific genotypes in a SNP (rs174537) strongly associated with FADS1 activity and PUFA metabolism.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT soybean oil and borage oil
Study Locations (1)
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-06-24 |
| Est. Completion | 2015-12-15 |
| Phase | NA |
What the finished NCT02337231 record still lists
NCT02337231 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Genetic Differences of Lipid Metabolism/Healthy Subjects appearing as the primary indexed condition, and to 1 intervention - of which soybean oil and borage oil is the first listed.
NCT02337231 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02337231 about?
NCT02337231 is a clinical study titled "Botanical Oils Study to Determine Genetic Differences in the Way Your Body Processes Fats in Edible Oils". A randomized, controlled, cross-over clinical trial of borage oil vs soybean oil to determine whether the metabolism and/or impact of medium chain-polyunsaturated fatty acids (MC-PUFAs) in botanical oil supplements are changed in relationship to specific genotypes in a SNP (rs174537) strongly associ...
What is the current status of trial NCT02337231?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2014-06-24. Estimated completion is 2015-12-15.
What conditions does trial NCT02337231 study?
This clinical trial studies the following conditions: Genetic Differences of Lipid Metabolism/Healthy Subjects.
What interventions are being tested in trial NCT02337231?
The interventions under investigation include: soybean oil and borage oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02337231?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02337231 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02337231's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI